QIAGEN is the leading provider of sample and assay technologies. Sampletechnologies are used to isolate DNA, RNA, and proteins from anybiological sample. Assay technologies are then used to make specifictarget biomolecules, such as the DNA of a specific virus, visible forsubsequent analysis. We have developed and market more than 500consumable products and automated solutions. The company provides theseproducts to molecular diagnostics laboratories, academic researchers,pharmaceutical and biotechnology companies, and applied testingcustomers for purposes such as forensics, animal or food testing andpharmaceutical process control. QIAGEN's assay technologies include oneof the broadest panels of molecular diagnostic tests availableworldwide. This panel includes the digene HPV Test, which is regarded asa "gold standard" in testing for high-risk types of humanpapillomavirus (HPV), the primary cause of cervical cancer, as well as abroad suite of solutions for infectious disease testing and companiondiagnostics. QIAGEN employs more than 3,600 people in over 35locations worldwide.